An International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac Function

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMatthias Stuber

About this trial

This project aims to evaluate a new cardiac MRI technique called the Free-Running Framework (FRF), which could simplify and accelerate the process of acquiring cardiac images. The investigators want to verify whether this method can provide functional heart measurements comparable to those obtained with traditional methods. More specifically, the goal of the study is to compare the measurements obtained with FRF to those obtained with standard sequences, to ensure they match and that this new approach can be reliably used in clinical practice. The FRF technique works differently from standard cardiac MRI. In standard exams, patients are asked to hold their breath several times and small electrodes (ECG) are used to monitor the heartbeat during the scan. These steps are needed to get clearer images of the heart as it moves. With FRF, these steps are no longer necessary: the scan is performed while patients' breath normally and without ECG monitoring. In addition, standard MRI takes multiple 2D slices of the heart, one after another. The FRF method instead captures a 3D image of the entire heart in one go, which can improve the consistency of the exam and reduce errors when doctors analyze the images later. This is all possible because the FRF method records data continuously and then organizes the images afterward based on how participants heart and breathing were moving during the exam. This helps the imager to get clear images of the heart, even without breath-holding or ECG monitoring. This project is aimed at individuals with heart disease who require cardiac MRI exams to monitor their health status (age ≥ 18 years) and are able to clearly understand the instructions provided by the research team. The investigators have already conducted small-scale technical and feasibility studies using FRF. These studies have shown that FRF is easy to use, faster than traditional methods, and provides image quality comparable to standard imaging techniques. The investigators now wish to evaluate its use in a clinical setting. More specifically, the investigators need to verify that FRF provides the same essential diagnostic information as standard techniques, so that it can be reliably used in future patient care. A maximum of 300 participants will be included in the investigation of this MRI technique between 2026 and 2031. This is a multi-center study, conducted internationally across 18 centers.

This project is being carried out in compliance with Swiss legislation. The investigators follow all internationally recognized guidelines. The competent ethics committee has reviewed and approved this project.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosed with cardiac disease of any complexity and scheduled for a clinical cardiac MRI on a clinical 1.5T MRI scanner

Able to understand and provide written informed consent or, for minors, ability to provide assent with written consent from a parent/legal representative, per local law and site policy prior to the study

Ability to undergo MRI without contraindications

Agrees to be informed in the event of incidental findings

Disqualifiers

Severe claustrophobia preventing MRI completion

Presence of non-MRI compatible implants (e.g., pacemakers, certain metallic implants)

Contraindications to the intravenous contrast agent

Movement disorders or inability to remain still during the scan

Trial population

This study will prospectively include 300 patients (\~15-20 per site) with known or suspected cardiac disease who are referred for a clinically indicated CMR scan as part of their routine clinical work-up.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

300 Participants
are grouped into 3 trial groups
Group A: Patients with congenital heart disease
Group B: Patients unable to perform breath-holding
Group C: Other cardiovascular disease patients who are able to perform breath-holding

Trial outcomes

Primary outcomes

1

mean paired difference (bias) in left ventricular ejection fraction (LVEF) between 5D FISS-FRF and conventional 2D cine CMR

estimated with a two-sided 95% confidence interval within each pre-defined patient cohort. The study is designed to ensure that the half-width of this confidence interval does not exceed 1.25% LVEF per cohort.

Time frame
Baseline (during study MRI acquisition)

Secondary outcomes

1

Scan Efficiency

* Sequence acquisition time: scanner-reported acquisition duration for 5D FISS-FRF and conventional 2D cine imaging. This will include the timing of the necessary localizers specific to the imaging plane for each acquisition mode. * Workflow time: elapsed time from initiation of cine planning to completion of cine acquisitions, including slice planning, patient instruction, rest between breath-holds, and repeated acquisitions when required.

Time frame
Baseline (during study MRI acquisition)
2

Quantitative Image Quality

o Contrast ratio and endocardial-to-blood-pool interface sharpness between 5D FISS-FRF and conventional 2D cine.

Time frame
Baseline (during study MRI acquisition)
3

Qualitative Image Quality

o Likert scale (0-4) consensus grading by ≥2 expert CMR readers blinded to images from both techniques.

Time frame
Baseline (during study MRI acquisition)
4

Failure Rate

o Percentage of non-diagnostic or excluded scans.

Time frame
Baseline (during study MRI acquisition)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Matthias Stuber

Lead sponsor

Centre Hospitalier Universitaire Vaudois

Sponsor institution

Mayo Clinic

Collaborator

University of California, Los Angeles

Collaborator

This trial is not recruiting at the moment. You can still explore other options: